|
Volumn 17, Issue SUPPL. 1, 2012, Pages
|
Thrombosis in rare bleeding disorders
|
Author keywords
Bleeding; Rare bleeding disorders; Thrombosis
|
Indexed keywords
ACTIVATED PROTHROMBIN COMPLEX;
ANTITHROMBIN;
BLOOD CLOTTING FACTOR 10;
BLOOD CLOTTING FACTOR 11;
BLOOD CLOTTING FACTOR 13;
BLOOD CLOTTING FACTOR 5;
BLOOD CLOTTING FACTOR 7;
FIBRINOGEN;
PROTHROMBIN;
RECOMBINANT BLOOD CLOTTING FACTOR 7A;
AFIBRINOGENEMIA;
ARTERY OCCLUSION;
ARTICLE;
BLEEDING DISORDER;
BLOOD CLOTTING FACTOR 11 DEFICIENCY;
BLOOD CLOTTING FACTOR 7 DEFICIENCY;
CENTRAL VENOUS CATHETER;
DISEASE ASSOCIATION;
DRUG ACTIVITY;
DYSFIBRINOGENEMIA;
FAMILIAL DISEASE;
FIBRINOGEN DEFECT;
GENETIC HETEROGENEITY;
HEART INFARCTION;
HEMOPHILIA A;
HEMOPHILIA B;
HETEROZYGOSITY;
HOMOZYGOSITY;
HUMAN;
NONHUMAN;
PATHOGENESIS;
PREVALENCE;
PRIORITY JOURNAL;
RARE DISEASE;
RISK FACTOR;
SUBSTITUTION THERAPY;
SURGICAL TECHNIQUE;
SYMPTOMATOLOGY;
THROMBOSIS;
VON WILLEBRAND DISEASE;
BLOOD COAGULATION DISORDERS, INHERITED;
FACTOR VII DEFICIENCY;
FACTOR XI DEFICIENCY;
FIBRINOGEN;
HEMORRHAGE;
HEMORRHAGIC DISORDERS;
HUMANS;
RARE DISEASES;
THROMBOSIS;
|
EID: 84859767422
PISSN: 10245332
EISSN: 16078454
Source Type: Journal
DOI: 10.1179/102453312X13336169156690 Document Type: Article |
Times cited : (21)
|
References (10)
|